• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
    • Why Should You Support SAGES?
    • SAGES Swag
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Annual Meeting
      • 2027 Scientific Session Call for Abstracts
      • 2027 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Lead Up Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • Innovative Surgical Trends
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Advanced Laparoscopy and Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
    • Foregut Video Atlas
  • Opportunities
    • Join the SAGES Patient Partner Network (PPN)
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs
  • Learning Hub
You are here: Home / Abstracts / Minimally invasive surgery for Siewert type II adenocarcinoma based on the distribution of lymph node metastasis or recurrence

Minimally invasive surgery for Siewert type II adenocarcinoma based on the distribution of lymph node metastasis or recurrence

Kazuo Koyanagi, MD, PhD1, Soji Ozawa, MD, PhD1, Kentaro Yatabe, MD1, Yamato Ninomiya, MD1, Miho Yamamoto, MD1, Akihito Yamamoto, MD1, Yuji Tachimori2. 1Department of Gastroenterological Surgery, Tokai University School of Medicine, 2Cancer Care Center, Kawasaki Saiwai Hospital

Aim: Based on the distribution of lymph node (LN) metastasis and LN recurrence of Siewert type II adenocarcinoma, appropriate surgical procedure was investigated, and also minimally invasive surgery for Siewert type II adenocarcinoma was introduced.

Methods: One hundred and sixty-eight patients with Siewert type II adenocarcinoma who underwent surgery without any neoadjuvant therapy between 2001 and 2016 were enrolled. Metastatic stations and recurrent LN sites were classified into five zones; cervical, upper/middle/lower, mediastinal, and abdominal zones. After investigating the correlation between LN metastasis or recurrence and esophageal invasion length (EIL) of the tumor, we have introduced a laparoscopic and thoracoscopic surgery for Siewert type II adenocarcinoma since 2018.

Results: Overall LN metastasis or recurrence in the cervical, upper/middle/lower, mediastinal LN zones were detected in 4, 8, 11, and 25 patients, respectively. Overall LN metastasis or recurrence in the abdominal LN zone was detected in 87 patients, however, metastasis or recurrence in No. 4 LN (LN along the short and left gastroepiploic artery) station was detected in only one patient. Siewert type II patients with an EIL of more than 25mm had a higher incidence of more advanced stage (P < 0.001) and more overall metastasis or recurrence rate in the upper (P = 0.01), middle (P < 0.001), and lower (P = 0.002) mediastinal zones than those with an EIL of less than or equal to 25mm. Based on these retrospective results, a laparoscopic and thoracoscopic surgery including the mediastinal LN dissection and intrathoracic reconstruction using gastric conduit have been introduced for Siewert type II tumors with invasion to the thoracic cavity. Prone position and overlap anastomosis for reconstruction were used during thoracoscopic procedure. We have conducted this procedure in three patients. Mean clinical EIL was 26mm, mean operative time was 587 min, blood loss was 268mL, and there were no intraoperative complications. Pathologically, mean length of proximal margin from the tumor was 63mm, and abdominal LN metastasis was detected in two patients, but no mediastinal LN metastasis were detected. Despite short follow-up period, no recurrence including LN recurrence were detected.

Conclusion: Appropriate area of LN dissection and reconstruction methods were investigated based on the analyses of distribution of LN metastasis once the tumor has invaded more than 25 mm to the esophageal wall in Siewert type II adenocarcinoma. Laparoscopic and thoracoscopic surgery should be less invasive and could be conducted safely.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 93863

Program Number: P512

Presentation Session: Poster Session (Non CME)

Presentation Type: Poster

View this Poster

Related



Hours & Info

15821 Ventura Blvd Ste 400
Encino, CA 91436

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2026 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

Refine Search